INS and type 2 diabetes mellitus: Third, rare mutations in Neurod1 in humans manifest as a subtype of maturity-onset diabetes of the young (MODY6)50–52, since NEUROD1 is one of the direct transcription activators of the insulin gene53–55, and is therefore, critical for modulating glucose homeostasis.